Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
•TECO Energy (NYSE:TE) reported Q4 diluted EPS of $0.26, slightly above the Zacks Consensus Estimate of $0.25 per share. Revenues for the quarter rose 1.3% year-over-year to $775.0 million, lower than the Zacks Consensus Estimate of $932.0 million
•GameStop (NYSE:GME) said its board of directors has approved $500 million as additional funds for its share and debt repurchase program
•Verizon Wireless (NYSE:VZ) reported that it has stopped taking preorders for the iPhone 4, 17 hours after the device went on sale at the carrier. The company stopped taking orders at 8:10 PM ET and reported that it sold more units of the popular Apple (NASDAQ:AAPL) device in the first two hours than any other device launch in its history
•Share prices of scientific instrument maker FEI Co (NASDAQ:FEIC) jumped 15.89% to $32.23 after the company’s projected first quarter analysis topped analyst’s expectations
•JDSU’s (NASDAQ:JDSU) share prices increased 26.92% to close at $22.76 after the company posted better than expected quarterly profits beating the Street’s expectations. JDSU is a provider of broadband components
•Drug-maker Biodel Inc (NASDAQ:BIOD) announced that launch of its experimental diabetes drug will be delayed because of further studies. Reacting to the news, share prices of Biodel fell 3.08%
•Coinstar Inc’s (NASDAQ:CSTR) share prices fell after the company reported lower than expected fourth quarter results
Read the full reports :
Analyst Report on TE
Analyst Report on GME
Analyst Report on VZ
Analyst Report on AAPL
Snapshot Report on FEIC
Analyst Report on JDSU
Snapshot Report on BIOD
Snapshot Report on CSTR